Marksans Pharma informs about transcript of earnings call

25 Nov 2024 Evaluate
Marksans Pharma has informed that it enclosed earnings call transcript for Q2FY25 financial performance and strategy update.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

320.95 -4.40 (-1.35%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.